Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Risk factors for chronic thromboembolic pulmonary hypertension - Importance of thyroid disease and function.

Krieg VJ, Hobohm L, Liebetrau C, Guth S, Kölmel S, Troidl C, Mayer E, Konstantinides SV, Wiedenroth CB, Lankeit M.

Thromb Res. 2019 Oct 31;185:20-26. doi: 10.1016/j.thromres.2019.10.025. [Epub ahead of print]

PMID:
31734602
2.

Atrial fibrillation is frequent but does not affect risk stratification in pulmonary embolism.

Ebner M, Rogge NIJ, Parwani AS, Sentler C, Lerchbaumer MH, Pieske B, Konstantinides SV, Hasenfuß G, Wachter R, Lankeit M.

J Intern Med. 2019 Oct 11. doi: 10.1111/joim.12985. [Epub ahead of print]

PMID:
31602725
3.

Survival Benefit of Obese Patients With Pulmonary Embolism.

Keller K, Hobohm L, Münzel T, Ostad MA, Espinola-Klein C, Lavie CJ, Konstantinides S, Lankeit M.

Mayo Clin Proc. 2019 Oct;94(10):1960-1973. doi: 10.1016/j.mayocp.2019.04.035.

PMID:
31585580
4.

Response to 'Detecting right ventricular dysfunction in patients diagnosed with low-risk pulmonary embolism: is routine computed tomographic pulmonary angiography sufficient?'

Barco S, Konstantinides SV, Lankeit M.

Eur Heart J. 2019 Oct 21;40(40):3357-3358. doi: 10.1093/eurheartj/ehz656. No abstract available.

PMID:
31539033
5.

[Pulmonary Embolism].

Hobohm L, Lankeit M.

Dtsch Med Wochenschr. 2019 Sep;144(18):1286-1300. doi: 10.1055/a-0670-5502. Epub 2019 Sep 12. German.

PMID:
31514220
6.

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS).

Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, Huisman MV, Humbert M, Jennings CS, Jiménez D, Kucher N, Lang IM, Lankeit M, Lorusso R, Mazzolai L, Meneveau N, Ní Áinle F, Prandoni P, Pruszczyk P, Righini M, Torbicki A, Van Belle E, Zamorano JL; ESC Scientific Document Group .

Eur Heart J. 2019 Aug 31. pii: ehz405. doi: 10.1093/eurheartj/ehz405. [Epub ahead of print] No abstract available.

PMID:
31504429
7.

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC).

Authors/Task Force Members:, Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, Huisman MV, Humbert M, Jennings CS, Jiménez D, Kucher N, Lang IM, Lankeit M, Lorusso R, Mazzolai L, Meneveau N, Áinle FN, Prandoni P, Pruszczyk P, Righini M, Torbicki A, Van Belle E, Zamorano JL.

Eur Respir J. 2019 Oct 9;54(3). pii: 1901647. doi: 10.1183/13993003.01647-2019. Print 2019 Sep. No abstract available.

PMID:
31473594
8.

Quality of life and functional limitations after pulmonary embolism and its prognostic relevance.

Keller K, Tesche C, Gerhold-Ay A, Nickels S, Klok FA, Rappold L, Hasenfuß G, Dellas C, Konstantinides SV, Lankeit M.

J Thromb Haemost. 2019 Nov;17(11):1923-1934. doi: 10.1111/jth.14589. Epub 2019 Aug 13.

PMID:
31344319
9.

Potential Involvement of Osteopontin in Inflammatory and Fibrotic Processes in Pulmonary Embolism and Chronic Thromboembolic Pulmonary Hypertension.

Kölmel S, Hobohm L, Käberich A, Krieg VJ, Bochenek ML, Wenzel P, Wiedenroth CB, Liebetrau C, Hasenfuß G, Mayer E, Konstantinides SV, Schäfer K, Guth S, Lankeit M.

Thromb Haemost. 2019 Aug;119(8):1332-1346. doi: 10.1055/s-0039-1692174. Epub 2019 Jun 10.

PMID:
31183846
10.

Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial.

Barco S, Schmidtmann I, Ageno W, Bauersachs RM, Becattini C, Bernardi E, Beyer-Westendorf J, Bonacchini L, Brachmann J, Christ M, Czihal M, Duerschmied D, Empen K, Espinola-Klein C, Ficker JH, Fonseca C, Genth-Zotz S, Jiménez D, Harjola VP, Held M, Iogna Prat L, Lange TJ, Manolis A, Meyer A, Mustonen P, Rauch-Kroehnert U, Ruiz-Artacho P, Schellong S, Schwaiblmair M, Stahrenberg R, Westerweel PE, Wild PS, Konstantinides SV, Lankeit M; HoT-PE Investigators .

Eur Heart J. 2019 May 23. pii: ehz367. doi: 10.1093/eurheartj/ehz367. [Epub ahead of print]

PMID:
31120118
11.

Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany.

Keller K, Hobohm L, Ebner M, Kresoja KP, Münzel T, Konstantinides SV, Lankeit M.

Eur Heart J. 2019 May 18. pii: ehz236. doi: 10.1093/eurheartj/ehz236. [Epub ahead of print]

PMID:
31102407
12.

Temporal trends in management and outcome of pulmonary embolism: a single-centre experience.

Ebner M, Kresoja KP, Keller K, Hobohm L, Rogge NIJ, Hasenfuß G, Pieske B, Konstantinides SV, Lankeit M.

Clin Res Cardiol. 2019 May 7. doi: 10.1007/s00392-019-01489-9. [Epub ahead of print]

PMID:
31065790
13.

Sex-specific differences in pulmonary embolism.

Keller K, Rappold L, Gerhold-Ay A, Hobohm L, Hasenfuß G, Konstantinides SV, Dellas C, Lankeit M.

Thromb Res. 2019 Jun;178:173-181. doi: 10.1016/j.thromres.2019.04.020. Epub 2019 Apr 23.

14.

Prediction and prognostic importance of in-hospital major bleeding in a real-world cohort of patients with pulmonary embolism.

Kresoja KP, Ebner M, Rogge NIJ, Sentler C, Keller K, Hobohm L, Hasenfuß G, Konstantinides SV, Pieske B, Lankeit M.

Int J Cardiol. 2019 Sep 1;290:144-149. doi: 10.1016/j.ijcard.2019.03.017. Epub 2019 Mar 16.

15.

Incidence and in-hospital safety outcomes of patients undergoing percutaneous mitral valve edge-to-edge repair using MitraClip: five-year German national patient sample including 13,575 implants.

von Bardeleben RS, Hobohm L, Kreidel F, Ostad MA, Schulz E, Konstantinides S, Lankeit M, Feldman T, Münzel T, Keller K.

EuroIntervention. 2019 Apr 20;14(17):1725-1732. doi: 10.4244/EIJ-D-18-00961.

16.

The Prognostic Value of Renal Function in Acute Pulmonary Embolism-A Multi-Centre Cohort Study.

Kostrubiec M, Pływaczewska M, Jiménez D, Lankeit M, Ciurzynski M, Konstantinides S, Pruszczyk P.

Thromb Haemost. 2019 Jan;119(1):140-148. doi: 10.1055/s-0038-1676522. Epub 2018 Dec 31.

PMID:
30597508
17.

Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial.

Barco S, Russo M, Vicaut E, Becattini C, Bertoletti L, Beyer-Westendorf J, Bouvaist H, Couturaud F, Danays T, Dellas C, Duerschmied D, Empen K, Ferrari E, Galiè N, Jiménez D, Klok FA, Kostrubiec M, Kozak M, Kupatt C, Lang IM, Lankeit M, Meneveau N, Palazzini M, Pruszczyk P, Rugolotto M, Salvi A, Sanchez O, Schellong S, Sobkowicz B, Meyer G, Konstantinides SV.

Clin Res Cardiol. 2019 Jul;108(7):772-778. doi: 10.1007/s00392-018-1405-1. Epub 2018 Dec 18.

18.

Differential impact of syncope on the prognosis of patients with acute pulmonary embolism: a systematic review and meta-analysis.

Barco S, Ende-Verhaar YM, Becattini C, Jimenez D, Lankeit M, Huisman MV, Konstantinides SV, Klok FA.

Eur Heart J. 2018 Dec 14;39(47):4186-4195. doi: 10.1093/eurheartj/ehy631.

PMID:
30339253
19.

Chronic thromboembolic pulmonary hypertension (CTEPH): Updated Recommendations from the Cologne Consensus Conference 2018.

Wilkens H, Konstantinides S, Lang IM, Bunck AC, Gerges M, Gerhardt F, Grgic A, Grohé C, Guth S, Held M, Hinrichs JB, Hoeper MM, Klepetko W, Kramm T, Krüger U, Lankeit M, Meyer BC, Olsson KM, Schäfers HJ, Schmidt M, Seyfarth HJ, Ulrich S, Wiedenroth CB, Mayer E.

Int J Cardiol. 2018 Dec 1;272S:69-78. doi: 10.1016/j.ijcard.2018.08.079. Epub 2018 Aug 28. Review.

PMID:
30195840
20.

Risk stratification of acute pulmonary embolism based on clinical parameters, H-FABP and multidetector CT.

Dellas C, Lobo JL, Rivas A, Ballaz A, Portillo AK, Nieto R, Del Rey JM, Zamorano JL, Lankeit M, Jiménez D.

Int J Cardiol. 2018 Aug 15;265:223-228. doi: 10.1016/j.ijcard.2018.04.066. Epub 2018 Apr 19. No abstract available.

PMID:
29705651
21.

Prognostic impact of copeptin in pulmonary embolism: a multicentre validation study.

Hellenkamp K, Pruszczyk P, Jiménez D, Wyzgał A, Barrios D, Ciurzyński M, Morillo R, Hobohm L, Keller K, Kurnicka K, Kostrubiec M, Wachter R, Hasenfuß G, Konstantinides S, Lankeit M.

Eur Respir J. 2018 Apr 19;51(4). pii: 1702037. doi: 10.1183/13993003.02037-2017. Print 2018 Apr.

22.

Improved identification of thrombolysis candidates amongst intermediate-risk pulmonary embolism patients: implications for future trials.

Barco S, Vicaut E, Klok FA, Lankeit M, Meyer G, Konstantinides SV; PEITHO Investigators.

Eur Respir J. 2018 Jan 18;51(1). pii: 1701775. doi: 10.1183/13993003.01775-2017. Print 2018 Jan. No abstract available.

23.

Always think of the right ventricle, even in "low-risk" pulmonary embolism.

Lankeit M.

Eur Respir J. 2017 Dec 14;50(6). pii: 1702386. doi: 10.1183/13993003.02386-2017. Print 2017 Dec. No abstract available.

24.

Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 Study.

Klok FA, Ageno W, Barco S, Binder H, Brenner B, Duerschmied D, Empen K, Faggiano P, Ficker JH, Galiè N, Ghuysen A, Held M, Heydenreich N, Huisman MV, Jiménez D, Kozak M, Lang IM, Lankeit M, Münzel T, Petris A, Pruszczyk P, Quitzau K, Schellong S, Schmidt KH, Stefanovic BS, Verschuren F, Wolf-Puetz A, Meyer G, Konstantinides SV; PEITHO-2 Investigators.

Thromb Haemost. 2017 Dec;117(12):2425-2434. doi: 10.1160/TH17-06-0434. Epub 2017 Dec 6.

PMID:
29212130
25.

[Medicinal treatment of tricuspid valve regurgitation].

Lankeit M, Keller K, Tschöpe C, Pieske B.

Herz. 2017 Nov;42(7):634-643. doi: 10.1007/s00059-017-4609-7. Review. German.

PMID:
28835976
26.

Pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension.

Lankeit M, Krieg V, Hobohm L, Kölmel S, Liebetrau C, Konstantinides S, Hamm CW, Mayer E, Wiedenroth CB, Guth S.

J Heart Lung Transplant. 2017 Jul 1. pii: S1053-2498(17)31877-6. doi: 10.1016/j.healun.2017.06.011. [Epub ahead of print]

PMID:
28750932
27.

Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism.

Konstantinides SV, Vicaut E, Danays T, Becattini C, Bertoletti L, Beyer-Westendorf J, Bouvaist H, Couturaud F, Dellas C, Duerschmied D, Empen K, Ferrari E, Galiè N, Jiménez D, Kostrubiec M, Kozak M, Kupatt C, Lang IM, Lankeit M, Meneveau N, Palazzini M, Pruszczyk P, Rugolotto M, Salvi A, Sanchez O, Schellong S, Sobkowicz B, Meyer G.

J Am Coll Cardiol. 2017 Mar 28;69(12):1536-1544. doi: 10.1016/j.jacc.2016.12.039.

28.

From thrombosis to fibrosis in chronic thromboembolic pulmonary hypertension.

Bochenek ML, Rosinus NS, Lankeit M, Hobohm L, Bremmer F, Schütz E, Klok FA, Horke S, Wiedenroth CB, Münzel T, Lang IM, Mayer E, Konstantinides S, Schäfer K.

Thromb Haemost. 2017 Apr 3;117(4):769-783. doi: 10.1160/TH16-10-0790. Epub 2017 Feb 2.

PMID:
28150849
29.

Pulmonary hypertension in heart failure with preserved ejection fraction: a plea for proper phenotyping and further research.

Hoeper MM, Lam CSP, Vachiery JL, Bauersachs J, Gerges C, Lang IM, Bonderman D, Olsson KM, Gibbs JSR, Dorfmuller P, Guazzi M, Galiè N, Manes A, Handoko ML, Vonk-Noordegraaf A, Lankeit M, Konstantinides S, Wachter R, Opitz C, Rosenkranz S.

Eur Heart J. 2017 Oct 7;38(38):2869-2873. doi: 10.1093/eurheartj/ehw597. No abstract available.

PMID:
28011705
30.

Temporal Trends in the Prevalence of Infective Endocarditis in Germany Between 2005 and 2014.

Keller K, von Bardeleben RS, Ostad MA, Hobohm L, Munzel T, Konstantinides S, Lankeit M.

Am J Cardiol. 2017 Jan 15;119(2):317-322. doi: 10.1016/j.amjcard.2016.09.035. Epub 2016 Oct 8.

PMID:
27816113
31.

Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment.

Klok FA, Hösel V, Clemens A, Yollo WD, Tilke C, Schulman S, Lankeit M, Konstantinides SV.

Eur Respir J. 2016 Nov;48(5):1369-1376. doi: 10.1183/13993003.00280-2016. Epub 2016 Jul 28.

32.

[Chronic thromboembolic pulmonary hypertension: Recommendations of the Cologne Consensus Conference 2016].

Wilkens H, Konstantinides S, Lang I, Bunck AC, Gerges M, Gerhardt F, Grgic A, Grohé C, Guth S, Held M, Hinrichs J, Hoeper MM, Klepetko W, Kramm T, Krüger U, Lankeit M, Meyer BC, Olsson KM, Schäfers HJ, Schmidt M, Seyfarth HJ, Ulrich S, Wiedenroth CB, Mayer E.

Dtsch Med Wochenschr. 2016 Oct;141(S 01):S62-S69. Epub 2016 Oct 19. Review. German.

PMID:
27760452
33.

Late outcomes after acute pulmonary embolism: rationale and design of FOCUS, a prospective observational multicenter cohort study.

Konstantinides SV, Barco S, Rosenkranz S, Lankeit M, Held M, Gerhardt F, Bruch L, Ewert R, Faehling M, Freise J, Ghofrani HA, Grünig E, Halank M, Heydenreich N, Hoeper MM, Leuchte HH, Mayer E, Meyer FJ, Neurohr C, Opitz C, Pinto A, Seyfarth HJ, Wachter R, Zäpf B, Wilkens H, Binder H, Wild PS.

J Thromb Thrombolysis. 2016 Nov;42(4):600-9. doi: 10.1007/s11239-016-1415-7.

34.

Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model.

Becattini C, Agnelli G, Lankeit M, Masotti L, Pruszczyk P, Casazza F, Vanni S, Nitti C, Kamphuisen P, Vedovati MC, De Natale MG, Konstantinides S.

Eur Respir J. 2016 Sep;48(3):780-6. doi: 10.1183/13993003.00024-2016. Epub 2016 May 12.

35.

Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban. Rationale and design of the HoT-PE Trial.

Barco S, Lankeit M, Binder H, Schellong S, Christ M, Beyer-Westendorf J, Duerschmied D, Bauersachs R, Empen K, Held M, Schwaiblmair M, Fonseca C, Jiménez D, Becattini C, Quitzau K, Konstantinides S.

Thromb Haemost. 2016 Jul 4;116(1):191-7. doi: 10.1160/TH16-01-0004. Epub 2016 Mar 24. Erratum in: Thromb Haemost. 2016 Sep 27;116(4):775.

PMID:
27010343
36.

Management of Pulmonary Embolism: An Update.

Konstantinides SV, Barco S, Lankeit M, Meyer G.

J Am Coll Cardiol. 2016 Mar 1;67(8):976-90. doi: 10.1016/j.jacc.2015.11.061. Review.

37.

Incidence of venous thromboembolism in COPD: linking inflammation and thrombosis?

Lankeit M, Held M.

Eur Respir J. 2016 Feb;47(2):369-73. doi: 10.1183/13993003.01679-2015. No abstract available.

38.

Outcome of patients with right heart thrombi: the Right Heart Thrombi European Registry.

Koć M, Kostrubiec M, Elikowski W, Meneveau N, Lankeit M, Grifoni S, Kuch-Wocial A, Petris A, Zaborska B, Stefanović BS, Hugues T, Torbicki A, Konstantinides S, Pruszczyk P; RiHTER Investigators.

Eur Respir J. 2016 Mar;47(3):869-75. doi: 10.1183/13993003.00819-2015. Epub 2016 Jan 21.

39.

Comparison of risk assessment strategies for not-high-risk pulmonary embolism.

Hobohm L, Hellenkamp K, Hasenfuß G, Münzel T, Konstantinides S, Lankeit M.

Eur Respir J. 2016 Apr;47(4):1170-8. doi: 10.1183/13993003.01605-2015. Epub 2016 Jan 7.

40.

Effectiveness of prognosticating pulmonary embolism using the ESC algorithm and the Bova score.

Jimenez D, Lobo JL, Fernandez-Golfin C, Portillo AK, Nieto R, Lankeit M, Konstantinides S, Prandoni P, Muriel A, Yusen RD; PROTECT investigators.

Thromb Haemost. 2016 Apr;115(4):827-34. doi: 10.1160/TH15-09-0761. Epub 2016 Jan 7.

PMID:
26738514
41.

Derivation of a clinical prediction score for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism.

Klok FA, Dzikowska-Diduch O, Kostrubiec M, Vliegen HW, Pruszczyk P, Hasenfuß G, Huisman MV, Konstantinides S, Lankeit M.

J Thromb Haemost. 2016 Jan;14(1):121-8. doi: 10.1111/jth.13175. Epub 2015 Dec 29.

42.

Risk stratification of normotensive pulmonary embolism: prognostic impact of copeptin.

Hellenkamp K, Schwung J, Rossmann H, Kaeberich A, Wachter R, Hasenfuß G, Konstantinides S, Lankeit M.

Eur Respir J. 2015 Dec;46(6):1701-10. doi: 10.1183/13993003.00857-2015. Epub 2015 Oct 22.

43.

Corrigendum to: 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism.

Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs J, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M; Authors/Task Force Members.

Eur Heart J. 2015 Oct 14;36(39):2642. doi: 10.1093/eurheartj/ehu479. Epub 2015 Jul 28. No abstract available.

PMID:
26224077
44.

Risk stratification of normotensive pulmonary embolism based on the sPESI - Does it work for all patients?

Hellenkamp K, Kaeberich A, Schwung J, Konstantinides S, Lankeit M.

Int J Cardiol. 2015 Oct 15;197:162-3. doi: 10.1016/j.ijcard.2015.06.065. Epub 2015 Jun 27. No abstract available.

PMID:
26142198
45.

Performance of five different bleeding-prediction scores in patients with acute pulmonary embolism.

Klok FA, Niemann C, Dellas C, Hasenfuß G, Konstantinides S, Lankeit M.

J Thromb Thrombolysis. 2016 Feb;41(2):312-20. doi: 10.1007/s11239-015-1239-x.

PMID:
26091712
46.

[Follow-up after acute pulmonary embolism. A prospective non-interventional multi-center cohort study (FOCUS)].

Konstantinides SV, Lankeit M, Wild P, Quitzau K, Binder H; im Auftrag der FOCUS-Investigatoren.

Dtsch Med Wochenschr. 2015 Jun;140 Suppl 1:S20-1. doi: 10.1055/s-0041-101767. Epub 2015 Jun 11. German. No abstract available.

PMID:
26069042
47.

CardioPulse: the 'Young Thrombosis Researchers Group' of the ESC Working Group on Thrombosis.

Grove EL, Lankeit M, Hess K, Freynhofer M, Stojkovic S, Varenhorst C, Thomas M.

Eur Heart J. 2015 Mar 21;36(12):703-4. No abstract available.

PMID:
25961094
48.

Corrigendum to: 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism.

Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs J, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M; Authors/Task Force Members.

Eur Heart J. 2015 Oct 14;36(39):2666. doi: 10.1093/eurheartj/ehv131. Epub 2015 Apr 20. No abstract available.

PMID:
25896079
49.

External validation of a simple non-invasive algorithm to rule out chronic thromboembolic pulmonary hypertension after acute pulmonary embolism.

Klok FA, Tesche C, Rappold L, Dellas C, Hasenfuß G, Huisman MV, Konstantinides S, Lankeit M.

Thromb Res. 2015 May;135(5):796-801. doi: 10.1016/j.thromres.2014.12.009. Epub 2014 Dec 13.

PMID:
25746363
50.

Validation of a Model for Identification of Patients at Intermediate to High Risk for Complications Associated With Acute Symptomatic Pulmonary Embolism.

Fernández C, Bova C, Sanchez O, Prandoni P, Lankeit M, Konstantinides S, Vanni S, Fernández-Golfín C, Yusen RD, Jiménez D.

Chest. 2015 Jul;148(1):211-218. doi: 10.1378/chest.14-2551.

PMID:
25633724

Supplemental Content

Loading ...
Support Center